| Literature DB >> 30884226 |
Wesley G Cochrane, Marie L Malone, Vuong Q Dang, Valerie Cavett, Alexander L Satz1, Brian M Paegel.
Abstract
Robotic high-throughput compound screening (HTS) and, increasingly, DNA-encoded library (DEL) screening are driving bioactive chemical matter discovery in the postgenomic era. HTS enables activity-based investigation of highly complex targets using static compound libraries. Conversely, DEL grants efficient access to novel chemical diversity, although screening is limited to affinity-based selections. Here, we describe an integrated droplet-based microfluidic circuit that directly screens solid-phase DELs for activity. An example screen of a 67 100-member library for inhibitors of the phosphodiesterase autotaxin yielded 35 high-priority structures for nanomole-scale synthesis and validation (20 active), guiding candidate selection for synthesis at scale (5/5 compounds with IC50 values of 4-10 μM). We further compared activity-based hits with those of an analogous affinity-based DEL selection. This miniaturized screening platform paves the way toward applying DELs to more complex targets (signaling pathways, cellular response) and represents a distributable approach to small molecule discovery.Entities:
Keywords: DNA-encoded library; OBOC; droplet; drug discovery; microfluidics
Mesh:
Substances:
Year: 2019 PMID: 30884226 PMCID: PMC6786493 DOI: 10.1021/acscombsci.9b00037
Source DB: PubMed Journal: ACS Comb Sci ISSN: 2156-8944 Impact factor: 3.784